| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 11.310 | 8.400 | 5.774 | 3.028 | 0 | 0 | 0 | 346 | 1.444 | 0 |
| Total Income - EUR | 11.310 | 8.456 | 5.819 | 3.028 | 0 | 0 | 0 | 346 | 1.444 | 0 |
| Total Expenses - EUR | 13.194 | 13.061 | 15.143 | 8.711 | 10.942 | 2.490 | 1.943 | 1.098 | 2.185 | 473 |
| Gross Profit/Loss - EUR | -1.884 | -4.605 | -9.324 | -5.683 | -10.942 | -2.490 | -1.943 | -752 | -741 | -473 |
| Net Profit/Loss - EUR | -2.223 | -4.690 | -9.382 | -5.714 | -10.942 | -2.490 | -1.943 | -762 | -746 | -473 |
| Employees | 2 | 2 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Adonis Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 31.385 | 29.410 | 27.286 | 25.188 | 18.641 | 17.214 | 15.783 | 15.832 | 15.784 | 15.696 |
| Current Assets | 6.688 | 3.639 | 175 | 506 | 915 | 945 | 863 | 924 | 787 | 4.258 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 879 | 841 | 42 | 461 | 840 | 859 | 809 | 812 | 739 | 4.258 |
| Cash | 5.809 | 2.798 | 133 | 45 | 75 | 86 | 54 | 113 | 48 | 0 |
| Shareholders Funds | 35.518 | 30.466 | 20.568 | 14.477 | 4.807 | 2.226 | 233 | -528 | -1.273 | -1.739 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.555 | 2.584 | 6.893 | 11.217 | 14.748 | 15.934 | 16.412 | 17.285 | 17.844 | 21.693 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6820 - 6820" | |||||||||
| CAEN Financial Year |
6820
|
|||||||||
Comments - Adonis Med Srl